11 May Ensuring Accurate Medical Translations for Contract Research Organizations (CROs)
In today’s world, at least in developed countries, people tend to live longer. Therefore, research on curing or minimizing ailments has a huge field. At the same time, each treatment needs testing and approval in each country, and the needs for good medical translation is part of the process.
CROs need accurate medical translations
Contract Research Organizations (CROs) emerged during the late 1990s. They appeared as a response to the increasing regulatory complexity faced by pharmaceutical and biopharmaceutical companies during research and development stages.
A Contract Research Organization, also known as a Clinical Research Organization, provides support services to biotechnology companies and pharmaceutical manufacturers. CROs may also include universities, foundations, research institutions, colleges, or government organizations operating in the clinical research sector.
These organizations require professional translation services during clinical trials and regulatory processes. Large amounts of documentation must be translated accurately and delivered on time. Choosing the right medical translation company is therefore essential. A reliable process, clear methodology, and high-quality standards can prevent delays and additional expenses. More importantly, accurate medical translations help avoid legal penalties and potential risks to patient safety.
Having accurate medical translations delivered on time is critical for the success of any clinical trial.
Outsourcing medical translations
Clinical trials are global by nature. Pharmaceutical companies invest large amounts of money into research, so treatments are usually developed for international approval and commercialization.
This means companies must comply with the regulations of every target country. Regulatory submissions often require accurate medical translations of key documents into local languages. These documents may include clinical summary reports, investigator brochures, regulatory documentation, and patient informed consent forms.
A clear example is the European Union market, which includes 24 official languages.
For this reason, many CROs outsource translation tasks to specialized medical translation companies. Outsourcing is often more cost-effective than maintaining large in-house translation teams.
CROs already manage many responsibilities during clinical trials. Their duties may include laboratory analysis, experimental design, manufacturing, pre-clinical studies, project management, clinical trial management, statistical analysis, and IRB approval processes.
As a result, outsourcing accurate medical translations allows CROs to focus on their core activities while ensuring compliance with local regulatory requirements and language standards.
Security techniques applied to obtain accurate medical translations
Several quality-control techniques help ensure accurate medical translations and reduce the risk of delays or regulatory problems.
One common method is back translation. In this process, a second translator translates the completed document back into the original language without seeing the source text. This technique helps identify inconsistencies or misunderstandings.
Another important technique is cognitive debriefing. This process evaluates whether the target audience fully understands the translated content.
Proofreading is also essential. A third person carefully reviews the document to detect and correct possible errors before final delivery.
Translation reviews are another important step. Once the translation is complete, another professional translator reviews the document and compares it directly with the original text. The reviewer may correct mistakes or improve readability to ensure the document sounds natural in the target language. Afterwards, the revised version is usually returned to the original translator for validation and discussion.
Both CROs and their sponsors understand the importance of accurate medical translations. High-quality multilingual communication remains a key factor in the success of international clinical trials.
No Comments